Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Thursday, 9th May 2024 ARWR stock ended at $24.72. This is 1.98% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.05% from a day low at $24.59 to a day high of $25.34.
90 days $21.39 $36.72
52 weeks $20.67 $40.89

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Jan 30, 2020 $43.74 $44.33 $41.06 $41.52 2 119 536
Jan 29, 2020 $45.20 $45.95 $43.85 $44.04 1 205 595
Jan 28, 2020 $44.41 $45.66 $44.23 $45.40 1 145 455
Jan 27, 2020 $43.05 $44.80 $42.39 $44.01 1 612 246
Jan 24, 2020 $46.34 $47.31 $43.64 $44.61 2 243 543
Jan 23, 2020 $47.22 $47.71 $46.19 $46.21 1 520 123
Jan 22, 2020 $47.59 $49.34 $47.41 $47.58 1 826 148
Jan 21, 2020 $52.35 $52.75 $46.48 $47.59 6 871 572
Jan 17, 2020 $57.69 $57.69 $56.11 $56.42 1 541 532
Jan 16, 2020 $57.12 $57.98 $56.75 $57.11 1 170 091
Jan 15, 2020 $58.00 $58.00 $56.60 $56.93 1 204 004
Jan 14, 2020 $55.87 $58.21 $54.67 $57.50 1 457 725
Jan 13, 2020 $58.00 $58.00 $54.19 $56.66 2 093 118
Jan 10, 2020 $59.04 $59.80 $57.65 $58.01 1 396 439
Jan 09, 2020 $60.46 $60.65 $58.58 $58.94 1 423 381
Jan 08, 2020 $59.72 $61.29 $58.75 $59.80 1 422 896
Jan 07, 2020 $59.13 $60.40 $58.21 $59.58 1 495 438
Jan 06, 2020 $60.91 $61.13 $58.73 $59.44 1 806 490
Jan 03, 2020 $61.94 $63.21 $60.77 $61.56 1 444 783
Jan 02, 2020 $63.62 $64.00 $60.75 $63.12 1 579 800
Dec 31, 2019 $63.94 $64.98 $63.21 $63.43 1 199 514
Dec 30, 2019 $64.50 $65.20 $63.20 $64.20 1 202 510
Dec 27, 2019 $67.15 $67.24 $63.71 $64.93 1 398 115
Dec 26, 2019 $64.55 $67.98 $64.34 $66.99 1 440 602
Dec 24, 2019 $63.61 $64.70 $63.02 $64.56 786 893
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT